U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071051) titled 'Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study' on July 08.

Brief Summary: This study evaluates the impact of calaspargase pegol (Cal-PEG) on the coagulation system in pediatric patients with acute lymphoblastic leukemia/lymphoma (ALL).

Study Start Date: Aug. 01

Study Type: OBSERVATIONAL

Condition: Childhood Acute Lymphoblastic Leukemia Childhood Lymphoblastic Lymphoma

Intervention: OTHER: Non-Interventional Study

Non-interventional study

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mayo Clinic

Published by HT Digital Content Ser...